CLINICAL ROLE -
Panelists compare the currently available RSV vaccines for adults, considering their target populations, dosing, and administration to prevent RSV infection.
Respiratory Syncytial Virus in Older Patients: Prevention, Management, and Long-Term Impact
Research Suggests Acute Cardiac Events Are Common in Older Adults Hospitalized With RSV
Study Highlights Reduced Disease Severity When Vaccinated Against RSV
RSV Vaccine Could Prevent Increased Risk of Disease Among Individuals Aged 18 to 59
Safety Data Confirm Viability of Flu, RSV Vaccines For Patients at Risk of Heart Failure
Bonding of RSV Prefusion F Proteins Display Potency Advantages